Iterum Therapeutics Plc Profit Margin

The latest profit margin for ITRM is -6913.08% as of September 2025. That compares with -1166.18% in the prior-year period — down 492.8% year over year. That is below the Healthcare sector average of 13.89%. Investors often review this figure alongside Iterum Therapeutics Plc's historical trend and sector peers before judging valuation or financial health.

Over the past year, ITRM's profit margin moved from -1166.18% to -6913.08% — a 492.8% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Iterum Therapeutics Plc's valuation or profitability profile.

Against Healthcare companies, ITRM currently prints -6913.08% for profit margin, while the sector average sits near 13.89%. That is roughly 49859.2% below the sector mean. Large gaps often invite a closer look at Iterum Therapeutics Plc's growth, margins, and balance sheet.

Profit Margin shows how effectively Iterum Therapeutics Plc converts resources into returns. At -6913.08%, ITRM may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -1166.18% in the prior-year period — down 492.8% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting ITRM's profit margin (-6913.08%), review year-over-year change from -1166.18%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.